Clinical Trials Browser

Phase 2 × INDUSTRY × Cholestasis × Clear all

NCT00080236 2012-08-10

Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation

Phase 2 Completed

Gastrointestinal

Cholestasis, Hepatitis, Carcinoma, Hepatocellular